Zafirlukast is used to prevent asthma symptoms and to decrease the number of asthma attacks in people 5 and older. It is an orally administered leukotriene receptor antagonist. Reference standards of Zafirlukast API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Dicyclopentyl (3,3'-((2-methoxy-4-((o-tolylsulfonyl)carbamoyl)phenyl)methylene)bis(1-methyl-1H-indole-5,3-diyl))dicarbamate [catalogue_number] => PA 26 01540 [category_ids] => ,79,80,71,75,78,70,82,88, [chemical_name] => [weight] => 831.97 [form] => C46H49N5O8S [cas] => 1160235-24-4 [pslug] => 1160235-24-4-dicyclopentyl-3-3-2-methoxy-4-o-tolylsulfonyl-carbamoyl-phenyl-methylene-bis-1-methyl-1h-indole-5-3-diyl-dicarbamate-pa2601540 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 26 01540
CAS :
Molecular Formula : C46H49N5O8S
Molecular Weight : 831.97
stdClass Object ( [pname] => Cyclopentyl (2,3-bis(2-Methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methyl-1H-indol-5-yl)carbamate [catalogue_number] => PA 26 01550 [category_ids] => ,79,80,71,81,76,75,78,70,82,88, [chemical_name] => [weight] => 893.03 [form] => C47H48N4O10S2 [cas] => 1160235-26-6 [pslug] => 1160235-26-6-cyclopentyl-2-3-bis-2-methoxy-4-o-tolylsulfonyl-carbamoyl-benzyl-1-methyl-1h-indol-5-yl-carbamate-pa2601550 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 26 01550
Molecular Formula : C47H48N4O10S2
Molecular Weight : 893.03
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
